Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,759 shares of the biotechnology company’s stock after selling 803 shares during the quarter. King Luther Capital Management Corp’s holdings in Axon Enterprise were worth $3,554,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of AXON. Fifth Third Bancorp raised its holdings in Axon Enterprise by 50.9% during the third quarter. Fifth Third Bancorp now owns 972 shares of the biotechnology company’s stock worth $193,000 after purchasing an additional 328 shares in the last quarter. Teacher Retirement System of Texas raised its holdings in shares of Axon Enterprise by 3.9% in the 3rd quarter. Teacher Retirement System of Texas now owns 5,438 shares of the biotechnology company’s stock worth $1,082,000 after purchasing an additional 204 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Axon Enterprise by 3.6% during the third quarter. Principal Financial Group Inc. now owns 87,012 shares of the biotechnology company’s stock worth $17,315,000 after buying an additional 3,055 shares in the last quarter. California Public Employees Retirement System grew its position in Axon Enterprise by 1.7% in the third quarter. California Public Employees Retirement System now owns 132,990 shares of the biotechnology company’s stock worth $26,464,000 after buying an additional 2,209 shares during the last quarter. Finally, Dai ichi Life Insurance Company Ltd lifted its position in shares of Axon Enterprise by 49.3% during the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 2,893 shares of the biotechnology company’s stock valued at $576,000 after acquiring an additional 955 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded down $1.98 during trading hours on Thursday, hitting $282.89. 114,222 shares of the stock were exchanged, compared to its average volume of 491,590. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The company’s 50 day moving average is $307.19 and its 200 day moving average is $273.52. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The firm has a market capitalization of $21.35 billion, a P/E ratio of 83.30 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The business’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.51 earnings per share. On average, research analysts expect that Axon Enterprise, Inc. will post 2.35 EPS for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the sale, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, insider Jeffrey C. Kunins sold 43,668 shares of Axon Enterprise stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the sale, the insider now directly owns 189,719 shares in the company, valued at approximately $58,801,506.86. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeri Williams sold 308 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 87,976 shares of company stock worth $27,268,201. Insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on AXON shares. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. JMP Securities restated a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Morgan Stanley boosted their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Finally, TheStreet lowered Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Read Our Latest Report on AXON

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.